Dual Organ Duel

The Hepatorenal Axis

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Recent developments in our understanding of the pathogenesis of kidney disease in the setting of liver failure have highlighted that kidney injury, rather than occurring in isolation, is a marker of systemic disease and poor prognosis. The differential diagnosis of kidney disease associated with liver failure is broader than formerly described and new biopsy data, along with better acute kidney injury classification tools, have increased appreciation for distinct pathophysiological mechanisms. Evidence suggests that acute kidney injury contributes to worsening hepatic failure by directly injuring hepatic cells and by imposing restrictions on therapeutic strategies for portal hypertension. Furthermore, kidney injury limits the use of various therapeutic agents and increases their toxicity due to altered pharmacodynamics. A greater appreciation of CKD in this population is also overdue because management decisions are affected and increased vigilance may avoid further kidney injury. A multidisciplinary approach to kidney injury in the setting of liver failure will enable targeted therapeutic strategies that are safe and effective and serve to guide further research, while limiting clinical potential for harm. Finally, new hepatitis C antiviral therapies promise to change the landscape of liver failure, and a discussion of kidney risk factors and antiviral therapy of patients with kidney disease and hepatitis C is worthwhile.

Original languageEnglish (US)
Pages (from-to)253-260
Number of pages8
JournalAdvances in Chronic Kidney Disease
Volume24
Issue number4
DOIs
StatePublished - Jul 1 2017

Fingerprint

Liver Failure
Kidney
Kidney Diseases
Wounds and Injuries
Hepatitis C
Acute Kidney Injury
Antiviral Agents
Portal Hypertension
Therapeutic Uses
Therapeutics
Hepatocytes
Differential Diagnosis
Biopsy
Research
Population

Keywords

  • Liver failure
  • Type of renal disease

ASJC Scopus subject areas

  • Nephrology

Cite this

Dual Organ Duel : The Hepatorenal Axis. / Golestaneh, Ladan; Neugarten, Joel.

In: Advances in Chronic Kidney Disease, Vol. 24, No. 4, 01.07.2017, p. 253-260.

Research output: Contribution to journalReview article

@article{b66b6dbd6ea24a168c0365f7bd419dc6,
title = "Dual Organ Duel: The Hepatorenal Axis",
abstract = "Recent developments in our understanding of the pathogenesis of kidney disease in the setting of liver failure have highlighted that kidney injury, rather than occurring in isolation, is a marker of systemic disease and poor prognosis. The differential diagnosis of kidney disease associated with liver failure is broader than formerly described and new biopsy data, along with better acute kidney injury classification tools, have increased appreciation for distinct pathophysiological mechanisms. Evidence suggests that acute kidney injury contributes to worsening hepatic failure by directly injuring hepatic cells and by imposing restrictions on therapeutic strategies for portal hypertension. Furthermore, kidney injury limits the use of various therapeutic agents and increases their toxicity due to altered pharmacodynamics. A greater appreciation of CKD in this population is also overdue because management decisions are affected and increased vigilance may avoid further kidney injury. A multidisciplinary approach to kidney injury in the setting of liver failure will enable targeted therapeutic strategies that are safe and effective and serve to guide further research, while limiting clinical potential for harm. Finally, new hepatitis C antiviral therapies promise to change the landscape of liver failure, and a discussion of kidney risk factors and antiviral therapy of patients with kidney disease and hepatitis C is worthwhile.",
keywords = "Liver failure, Type of renal disease",
author = "Ladan Golestaneh and Joel Neugarten",
year = "2017",
month = "7",
day = "1",
doi = "10.1053/j.ackd.2017.05.009",
language = "English (US)",
volume = "24",
pages = "253--260",
journal = "Advances in Chronic Kidney Disease",
issn = "1548-5595",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Dual Organ Duel

T2 - The Hepatorenal Axis

AU - Golestaneh, Ladan

AU - Neugarten, Joel

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Recent developments in our understanding of the pathogenesis of kidney disease in the setting of liver failure have highlighted that kidney injury, rather than occurring in isolation, is a marker of systemic disease and poor prognosis. The differential diagnosis of kidney disease associated with liver failure is broader than formerly described and new biopsy data, along with better acute kidney injury classification tools, have increased appreciation for distinct pathophysiological mechanisms. Evidence suggests that acute kidney injury contributes to worsening hepatic failure by directly injuring hepatic cells and by imposing restrictions on therapeutic strategies for portal hypertension. Furthermore, kidney injury limits the use of various therapeutic agents and increases their toxicity due to altered pharmacodynamics. A greater appreciation of CKD in this population is also overdue because management decisions are affected and increased vigilance may avoid further kidney injury. A multidisciplinary approach to kidney injury in the setting of liver failure will enable targeted therapeutic strategies that are safe and effective and serve to guide further research, while limiting clinical potential for harm. Finally, new hepatitis C antiviral therapies promise to change the landscape of liver failure, and a discussion of kidney risk factors and antiviral therapy of patients with kidney disease and hepatitis C is worthwhile.

AB - Recent developments in our understanding of the pathogenesis of kidney disease in the setting of liver failure have highlighted that kidney injury, rather than occurring in isolation, is a marker of systemic disease and poor prognosis. The differential diagnosis of kidney disease associated with liver failure is broader than formerly described and new biopsy data, along with better acute kidney injury classification tools, have increased appreciation for distinct pathophysiological mechanisms. Evidence suggests that acute kidney injury contributes to worsening hepatic failure by directly injuring hepatic cells and by imposing restrictions on therapeutic strategies for portal hypertension. Furthermore, kidney injury limits the use of various therapeutic agents and increases their toxicity due to altered pharmacodynamics. A greater appreciation of CKD in this population is also overdue because management decisions are affected and increased vigilance may avoid further kidney injury. A multidisciplinary approach to kidney injury in the setting of liver failure will enable targeted therapeutic strategies that are safe and effective and serve to guide further research, while limiting clinical potential for harm. Finally, new hepatitis C antiviral therapies promise to change the landscape of liver failure, and a discussion of kidney risk factors and antiviral therapy of patients with kidney disease and hepatitis C is worthwhile.

KW - Liver failure

KW - Type of renal disease

UR - http://www.scopus.com/inward/record.url?scp=85026537372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026537372&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2017.05.009

DO - 10.1053/j.ackd.2017.05.009

M3 - Review article

VL - 24

SP - 253

EP - 260

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

SN - 1548-5595

IS - 4

ER -